Jan 29 (Reuters) - NOVO NORDISK A/S:
* NOVO NORDISK SAYS DOES NOT INTEND TO MAKE A REVISED PROPOSAL FOR ABLYNX
* NOVO NORDISK SAYS LOOKS FORWARD TO CONTINUE ITS PRODUCTIVE RESEARCH COLLABORATION WITH ABLYNX
* FRENCH DRUGMAKER SANOFI SAID ON MONDAY IT HAS AGREED TO BUY THE BELGIAN BIOTECH COMPANY FOR 3.9 BILLION EUROS ($4.8 BILLION) FURTHER COMPANY COVERAGE: (Reporting by Stine Jacobsen)
 